Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines-Reference-Cited by-同舟云学术

Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines

Published:2017-04 Issue:2 Volume:21 Page:87-90
ISSN:1526-0976
Container-title:Journal of Lower Genital Tract Disease
language:en
Short-container-title:J Low Genit Tract Dis

Author:

Schiffman Mark,Wentzensen Nicolas,Khan Michelle J.,Castle Philip E.,Chelmow David,Huh Warner K.,Moscicki Anna Barbara,Stockdale Colleen K.,Darragh Teresa M.,Silver Michelle,Guido Richard S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology,General Medicine

Reference10 articles.

1. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance;J Low Genit Tract Dis,2015

2. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors;J Low Genit Tract Dis,2013

3. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer;CA Cancer J Clin,2012

4. 2001 consensus guidelines for the management of women with cervical cytological abnormalities;JAMA,2002

5. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ;J Low Genit Tract Dis,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is mRNA indeed Useful in Clinical Management of Cervical Pathology?;Research Anthology on Advancements in Women's Health and Reproductive Rights;2022-05-06

2. Is mRNA indeed Useful in Clinical Management of Cervical Pathology?;Handbook of Research on Oncological and Endoscopical Dilemmas in Modern Gynecological Clinical Practice;2021

3. Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review;Journal of Lower Genital Tract Disease;2020-10-27

4. Moving forward—the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories;Journal of the American Society of Cytopathology;2020-07

5. Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests;Journal of Lower Genital Tract Disease;2020-04